Baxter Healthcare Injectable Ondansetron Recalled for Failed pH Specifications
Baxter Healthcare Corporation is recalling approximately 6 million vials of Ondansetron Hydrochloride injection due to manufacturing defects where pH levels failed to meet specifications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for manufacturing defect affecting product specification. No illnesses or injuries have been reported in the source material; the hazard is a quality control failure posing theoretical risk.
Plain-English summary
Baxter Healthcare Corporation is recalling Ondansetron Hydrochloride Injection, USP (4 mg/2 mL) due to failed pH specifications. Ondansetron is an injectable medication used to prevent nausea and vomiting.
The recall affects approximately 6,022,675 vials distributed nationwide in the United States. The product was manufactured by Baxter Pharmaceuticals India Private Ltd and distributed under NDC 36000-012-25. Multiple lot numbers are affected with expiration dates ranging from November 2023 through October 2024.
Healthcare providers should not dispense affected vials. Patients currently using this medication should consult their healthcare provider for guidance. Retailers and distributors should quarantine and return affected lot numbers to Baxter Healthcare Corporation.
The recalled product
- Product
- ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)
- Brand
- ONDANSETRON HYDROCHLORIDE
- Manufacturer
- Baxter Healthcare Corporation
- Hazard
- manufacturing-defect
- failed-ph-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # A0E0959A
- A0E0961A
- A0E1015A
- A0E1020A
- Exp. Date 30-Nov-23
- A0F0016A
- Exp. Date 31-Dec-23
- A0F0260A
- A0F0261A
- A0F0262A
- Exp. Date 29-Feb-24
- A0F0414A
- A0F0415A
- A0F0416A
- A0F0417A
- A0F0418A
- Exp. Date 30-Apr-24
- A0F0503A
- Exp. Date 31-May-24
- A0F0533A
UPCs (1)
- 0336000012256
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ONDANSETRON HYDROCHLORIDE
- HighOndansetron Tablets Recalled for Temperature Exposure During Storage
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27